Floatz logo

Zofran

Stage IV Pancreatic Cancer AJCC v8

Fred Hutchinson Cancer CenterPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Stage IV Pancreatic Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
TME Pharma AG
Phase 3BB
Niraparib
OHSU Knight Cancer Institute
Phase 2BB
Dostarlimab
University of Washington
Phase 2BB
Palbociclib
National Cancer Institute (NCI)
Phase 2BB
Hydroxychloroquine
N.N. Petrov National Medical Research Center of Oncology
Phase 2B

View all 19 →

Same molecule, other indications

Zofran is also rated in:

NauseaDormant
BBB
Indicative ·
73 / 100
View asset →
VomitingDormant
BBB
Indicative ·
73 / 100
View asset →
Non-Hodgkin's LymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →